VELARU MANDATE EXHIBIT PACK — DIGITAL PATHOLOGY AI
Jurisdiction: New York (us_ny)
Modality: Text / Chat
Program: Velaru Digital Pathology AI · New York (galactic_pathology_ai_us_ny)
Product ID: pathology_ai:us_ny:bundle:text
Vertical: pathology_ai
Generated: 2026-08-23T19:53:05.912391Z
Authority: New York AI Governance Pack — Digital Pathology AI External Validation Pack
Deadline: NYDFS AI guidance + Local Law 144 enforcement
Velaru verify: https://velaru-erra.onrender.com/verify

EXHIBIT A — AI INVENTORY
[]

EXHIBIT B — GOVERNANCE FRAMEWORK
{
  "framework": "Velaru Mandate Registry \u2014 Digital Pathology AI",
  "exhibit_authority": "New York AI Governance Pack \u2014 Digital Pathology AI External Validation Pack",
  "regulatory_frameworks": [
    "HIPAA",
    "FDA SaMD guidance",
    "EU AI Act Annex III",
    "NYDFS Circular Letter on AI",
    "NYC Local Law 144",
    "Martin Act"
  ],
  "standards_alignment": [
    "POSS-2",
    "DRP-1",
    "TCB",
    "FRE 707 pre-compliance",
    "ISO 42001"
  ],
  "human_oversight": "execute Digital Pathology AI AI decision",
  "third_party_verification": "https://velaru-erra.onrender.com/verify (operator-independent)",
  "data_lineage": "Hash-chained Ed25519 receipts; optional RFC3161 + external anchor",
  "mirror_trap": "Niche Digital Pathology AI deployer owns AI harm \u2014 vertical SaaS vendor owns liability cap. \u00b7 Local Law 144 requires annual bias audit \u2014 Velaru receipts are continuous audit, not annual snapshot.",
  "chain_integrity": {
    "depth": 6,
    "invariant_holds": true
  }
}

EXHIBIT D — DATA INPUTS & VALIDATION
{
  "data_validation_method": "Cryptographic receipt per AI decision; public verify without trusting deployer, vendor, or Velaru operator",
  "bias_testing_proxy": "Asymmetry score from live chain signals",
  "model_change_control": "Policy lock registry \u2014 criteria hash frozen pre-dispute",
  "logging_retention": "90-day pre-dispute window minimum; permanent verify permalinks",
  "external_validator": "Nisaba LLC / Velaru",
  "validator_independence": "Client-side Ed25519 verify; BYOK tri-receipt optional",
  "headline_stat": "Digital Pathology AI \u2014 AI decision audit trail required for liability defense",
  "global_leaders_addressed": [
    "Sector regulators",
    "Vertical SaaS platforms",
    "NYDFS",
    "NYC DCWP",
    "Goldman Sachs",
    "MetLife"
  ]
}

MIRROR TRAP (regulatory insight)
Niche Digital Pathology AI deployer owns AI harm — vertical SaaS vendor owns liability cap. · Local Law 144 requires annual bias audit — Velaru receipts are continuous audit, not annual snapshot.

NERVE CARDS — WHY GLOBAL LEADERS CARE
[
  {
    "title": "Niche litigation",
    "body": "Digital Pathology AI plaintiffs challenge AI decision without independent verify.",
    "source": "vertical"
  },
  {
    "title": "Insurance bind",
    "body": "Sector insurers asking AI governance questions on Digital Pathology AI accounts.",
    "source": "vertical"
  },
  {
    "title": "[New York] Financial capital",
    "body": "NYDFS regulates insurers AND banks \u2014 same receipt primitive for both books.",
    "source": "jurisdiction"
  },
  {
    "title": "[New York] Hiring audit law",
    "body": "NYC AEDT law is template for other cities \u2014 receipt architecture scales municipally.",
    "source": "jurisdiction"
  },
  {
    "title": "[Text / Chat] Modality hook",
    "body": "Baseline \u2014 all frameworks apply to text decisions.",
    "source": "modality"
  }
]

BOOK SUMMARY: {
  "total_insureds": 0,
  "compliant": 0,
  "grace_period": 0,
  "non_compliant": 0,
  "expired": 0,
  "not_enrolled": 0,
  "compliant_pct": 0.0
}

TAM / EXPOSURE: Global Digital Pathology AI market
INSURANCE LINES: E&O, Cyber, Sector liability

DISCLAIMER: External validation evidence pack — not legal advice, not filed rate approval.